Endonovo Announces Partnership with Santana Lead Singer Andy Vargas
April 10, 2023 12:01 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 10, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc (OTCQB: ENDV) -- a pioneer in bioelectronic medical devices -- announced today its partnership with world-renowned...
Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company
March 29, 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 29, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced a binding Letter of Intent (LOI) to spin off its current medical device division to an...
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan
March 23, 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 23, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a medical device company known for its innovative and effective pain management solutions --...
Olympian and Champion Surfer Carlos Muñoz Turns To SofPulse® For Accelerated Recovery After Invasive Shoulder Surgery
March 15, 2023 09:05 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 15, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) announced details today of the remarkable experience of one of its Scientific Advisory Board Members,...
Endonovo Announces Distribution Agreement with Academy Medical
March 06, 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Provide Improved Medical Services to VHA and U.S. Dept. of Defense Los Angeles, CA, March 06, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the signing of a...
Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg
February 28, 2023 09:09 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a medical device company specializing in pulsed electromagnetic field (PEMF) technology, announced today...
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off
January 31, 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the retention of Ocean Tomo, a part of J.S. Held, to conduct a fairness opinion analysis...
Endonovo Partners with International Distributor for SofPulse® Line
January 26, 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Partnership Expected to Increase SofPulse® Distribution and Revenues Los Angeles, CA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced a new...
New Details on Endonovo’s Spin-Off of SofPulse, Inc.
January 19, 2023 09:05 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) announced today details regarding the planned spin-off of its medical device assets to a newly formed...
Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Company
January 09, 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced details for its plan to spin off its current medical device division, known as NewCo, as a...